Literature DB >> 15167006

Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies.

Julie L Ryan1, Hongxin Fan, Lode J Swinnen, Steven A Schichman, Nancy Raab-Traub, Mary Covington, Sandra Elmore, Margaret L Gulley.   

Abstract

Epstein-Barr Virus (EBV), a ubiquitous gamma herpes virus, infects more than 95% of the human population before adulthood. Life-long persistence, usually without adverse health consequences, relies on a balance between viral latency, viral replication, and host immune response. Patients with EBV-related disease often have high levels of EBV DNA in their plasma. This study addresses whether this circulating, cell-free EBV DNA is encapsidated in virions or exists as naked genomes. First, an assay was developed, combining DNase I and quantitative real-time PCR, to discriminate encapsidated from naked EBV DNA. EBV DNA was almost always naked in the plasma of AIDS-related lymphoma patients (n = 11) and immunosuppressed/posttransplantation patients (n = 8). In contrast, infectious mononucleosis patients (n = 30) often had a mixture of encapsidated and naked EBV DNA. These findings may be important in understanding how viral load relates to disease status and in predicting response to nucleoside analogs and other antiviral therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167006     DOI: 10.1097/00019606-200406000-00001

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  24 in total

1.  Viral response to chemotherapy in endemic burkitt lymphoma.

Authors:  Weihua Tang; Paula Harmon; Margaret L Gulley; Charles Mwansambo; Peter N Kazembe; Francis Martinson; Clifford Wokocha; Shannon C Kenney; Irving Hoffman; Carlie Sigel; Susan Maygarden; Mariah Hoffman; Carol Shores
Journal:  Clin Cancer Res       Date:  2010-03-16       Impact factor: 12.531

2.  Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.

Authors:  Margaret L Gulley; Hongxin Fan; Sandra H Elmore
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

3.  Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.

Authors:  Katherine D Westmoreland; Nathan D Montgomery; Christopher C Stanley; Nader Kim El-Mallawany; Peter Wasswa; Toon van der Gronde; Idah Mtete; Mercy Butia; Salama Itimu; Mary Chasela; Mary Mtunda; Coxcilly Kampani; N George Liomba; Tamiwe Tomoka; Bal M Dhungel; Marcia K Sanders; Robert Krysiak; Peter Kazembe; Dirk P Dittmer; Yuri Fedoriw; Satish Gopal
Journal:  Int J Cancer       Date:  2017-03-24       Impact factor: 7.396

Review 4.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

5.  Does Size Matter? Comparison of Extraction Yields for Different-Sized DNA Fragments by Seven Different Routine and Four New Circulating Cell-Free Extraction Methods.

Authors:  Linda Cook; Kimberly Starr; Jerry Boonyaratanakornkit; Randall Hayden; Soya S Sam; Angela M Caliendo
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

6.  Regulation of autophagic activation by Rta of Epstein-Barr virus via the extracellular signal-regulated kinase pathway.

Authors:  Chien-Hui Hung; Lee-Wen Chen; Wen-Hung Wang; Pey-Jium Chang; Ya-Fang Chiu; Chen-Chia Hung; Ying-Ju Lin; Jieh-Yuan Liou; Wan-Ju Tsai; Chia-Ling Hung; Shih-Tung Liu
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

7.  Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma.

Authors:  Jennifer J G Welch; Cindy L Schwartz; Meghan Higman; Lu Chen; Allen Buxton; Jennifer A Kanakry; Samir B Kahwash; Robert E Hutchison; Debra L Friedman; Richard F Ambinder
Journal:  Blood Adv       Date:  2017-04-24

Review 8.  Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

9.  Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.

Authors:  Jennifer A Kanakry; Hailun Li; Lan L Gellert; M Victor Lemas; Wen-son Hsieh; Fangxin Hong; King L Tan; Randy D Gascoyne; Leo I Gordon; Richard I Fisher; Nancy L Bartlett; Patrick Stiff; Bruce D Cheson; Ranjana Advani; Thomas P Miller; Brad S Kahl; Sandra J Horning; Richard F Ambinder
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

10.  The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.

Authors:  Jennifer A Kanakry; Aparna M Hegde; Christine M Durand; Allan B Massie; Amy E Greer; Richard F Ambinder; Alexandra Valsamakis
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.